T-Cell Large Granular Lymphocyte Leukemia

T-Cell Large Granular Lymphocyte Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05592015	Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia	recruiting	Phase 2	30	Jonathan BrammerOTHER	1	Feb 10, 2026	clinicaltrials
NCT06530576	Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia	recruiting	Phase 2	48	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Nov 18, 2025	clinicaltrials